Taevas
South AfricaMedical Devices
Product Registration
Market Access for Product-Registration in South Africa
Navigating the complexities of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve optimal market entry and sustained commercial success acr
Market
Global
Industry
Product-Registration
Regulator
National Health Authorities & Global Regulatory Bodies
Timeline
8-12 weeks (Strategic Phase)
Deliverables
Market Access Strategy, Payer Landscape Report, HTA Dossier Guidance
What We Deliver
6 Pillars of Global Market Access for Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Payer Landscape Assessment
Thorough analysis of international payer environments, identifying key decision-makers, reimbursement models, and market specific access hurdles. This foundational step informs all subsequent strategic planning.
Market-specific payer intelligence
Reimbursement pathway mapping
How It Works
How It Works: Our Global Market Access Process
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin with an in-depth assessment of your product, target markets, and the global regulatory and payer landscape. This phase identifies critical success factors and potential barriers.
Market Snapshot
Market Overview: Global Product Registration & Market Access Landscape
Increasing Regulatory Scrutiny
Global regulatory bodies are demanding more rigorous evidence of clinical benefit and cost-effectiveness, making market access strategies intrinsically linked to successful product registration.
Fragmented Payer Environments
The diversity of healthcare systems and reimbursement models across countries necessitates highly customized market access approaches, moving beyond a 'one-size-fits-all' strategy.
Rise of Value-Based Healthcare
Payers globally are shifting towards value-based reimbursement, requiring manufacturers to demonstrate real-world outcomes and economic value post-registration to secure and maintain access.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy Document
A detailed roadmap outlining market entry, pricing, reimbursement, and stakeholder engagement plans for key target markets.
Payer Landscape & Reimbursement Opportunity Report
An in-depth analysis of payer dynamics, policy trends, and reimbursement pathways in selected global regions, identifying strategic opportunities.
Health Technology Assessment (HTA) Readiness Assessment
Evaluation of your product's evidence package against HTA requirements, identifying gaps and providing strategic recommendations for dossier optimization.
Value Story & Messaging Framework
A customized framework for communicating your product's unique value proposition to diverse global stakeholders, including payers, clinicians, and patients.
Who This Is For
Use Cases
Biotech Startup
First Global Launch of an Orphan Drug
A biotech startup with a novel orphan drug faced challenges navigating complex and varied market access requirements across the EU, US, and Japan. Taevas developed a phased global strategy, focusing on early HTA engagement and patient advocacy.
Outcome
Achieved expedited market access and favorable reimbursement in multiple key markets, significantly accelerating patient access.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Accelerate Product Registration and Market Entry Globally?
Partner with Taevas Life Sciences to transform global market access challenges into strategic opportunities. Our authoritative guidance ensures your innovations reach patients worldwide efficiently and effectively.
Navigate complex global landscapes with confidence
Optimize pricing and reimbursement for maximum value
Secure faster and broader patient access
Leverage data-driven insights for strategic decisions